Showing results (861-870 of 885) with videos related to

Sort By:
Pageof 89
The Journal of Clinical Endocrinology and Metabolism|January 3, 2026
Diazoxide Choline Extended-Release Tablets in Prader-Willi Syndrome: A Randomized, Double-Blind, Withdrawal Period StudyJennifer L Miller, Nicola Bridges, Eric I Felner, et al.
Lancet (London, England)|September 6, 2011
Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort studyJuan P Wisnivesky, Susan L Teitelbaum, Andrew C Todd, et al.
American Journal of Medical Genetics. Part A|May 8, 2016
The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathwayDavid A Stevenson, Lisa Schill, Lisa Schoyer, et al.
Global Change Biology|April 21, 2015
Effects of climate change on the delivery of soil-mediated ecosystem services within the primary sector in temperate ecosystems: a review and New Zealand case studyKate H Orwin, Bryan A Stevenson, Simeon J Smaill, et al.
Frontiers in Molecular Biosciences|July 30, 2021
Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental PipelineEdmond Y Lau, Oscar A Negrete, W F Drew Bennett, et al.
The Journal of Investigative Dermatology|October 26, 2012
Copy number variation analysis in 98 individuals with PHACE syndromeDawn H Siegel, Joseph T C Shieh, Eun-Kyung Kwon, et al.
Molecular Cancer Therapeutics|June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of CancerDorin Toader, Shawn P Fessler, Scott D Collins, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 20, 2021
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendationEric Legius, Ludwine Messiaen, Pierre Wolkenstein, et al.
Neuro-Oncology|July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensusPeter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Genome Medicine|August 16, 2017
Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disordersBret L Bostwick, Scott McLean, Jennifer E Posey, et al.
Pageof 89